Global GLP-1 Drug Market Growth 2026-2032
The global GLP-1 Drug market size is predicted to grow from US$ 37570 million in 2025 to US$ 191030 million in 2032; it is expected to grow at a CAGR of 26.7% from 2026 to 2032.
United States market for GLP-1 Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GLP-1 Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GLP-1 Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GLP-1 Drug players cover Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Drug Industry Forecast” looks at past sales and reviews total world GLP-1 Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1 Drug sales for 2026 through 2032. With GLP-1 Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Drug industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for GLP-1 Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GLP-1 Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GLP-1 Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GLP-1 Drug players cover Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Drug Industry Forecast” looks at past sales and reviews total world GLP-1 Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1 Drug sales for 2026 through 2032. With GLP-1 Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Drug industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Short-acting GLP-1 Drug
- Long-acting GLP-1 Drug
- Obesity
- Type 2 Diabetes (T2DM)
- Cardiovascular and Cerebrovascular Diseases (CVD)
- Non-alcoholic Steatohepatitis (NASH)
- Alzheimer's Disease (AD)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Eli Lilly
- AstraZeneca
- Sanofi
- Pfizer Inc
- Hanmi Pharmaceutical Co
- Teva Pharmaceutical Industries Ltd
- Boehringer Ingelheim
- GlaxoSmithKline (GSK)
- Huadong Medicine
- Gan & Lee Pharmaceuticals
- Tonghua Dongbao
- Shanghai Benemae Pharmaceutical Corporation
- Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- PegBio Co., Ltd
- What is the 10-year outlook for the global GLP-1 Drug market?
- What factors are driving GLP-1 Drug market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do GLP-1 Drug market opportunities vary by end market size?
- How does GLP-1 Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GLP-1 Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GLP-1 Drug by Country/Region, 2021, 2025 & 2032
2.2 GLP-1 Drug Segment by Type
2.2.1 Short-acting GLP-1 Drug
2.2.2 Long-acting GLP-1 Drug
2.2.3 GLP-1 Drug Sales by Type
2.2.3.1 Global GLP-1 Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global GLP-1 Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global GLP-1 Drug Sale Price by Type (2021-2026)
2.3 GLP-1 Drug Segment by Application
2.3.1 Obesity
2.3.2 Type 2 Diabetes (T2DM)
2.3.3 Cardiovascular and Cerebrovascular Diseases (CVD)
2.3.4 Non-alcoholic Steatohepatitis (NASH)
2.3.5 Alzheimer's Disease (AD)
2.3.6 GLP-1 Drug Sales by Application
2.3.6.1 Global GLP-1 Drug Sale Market Share by Application (2021-2026)
2.3.6.2 Global GLP-1 Drug Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global GLP-1 Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Drug Breakdown Data by Company
3.1.1 Global GLP-1 Drug Annual Sales by Company (2021-2026)
3.1.2 Global GLP-1 Drug Sales Market Share by Company (2021-2026)
3.2 Global GLP-1 Drug Annual Revenue by Company (2021-2026)
3.2.1 Global GLP-1 Drug Revenue by Company (2021-2026)
3.2.2 Global GLP-1 Drug Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1 Drug Sale Price by Company
3.4 Key Manufacturers GLP-1 Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Drug Product Location Distribution
3.4.2 Players GLP-1 Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 DRUG BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global GLP-1 Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GLP-1 Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1 Drug Market Size by Country/Region (2021-2026)
4.2.1 Global GLP-1 Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global GLP-1 Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1 Drug Sales Growth
4.4 APAC GLP-1 Drug Sales Growth
4.5 Europe GLP-1 Drug Sales Growth
4.6 Middle East & Africa GLP-1 Drug Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Drug Sales by Country
5.1.1 Americas GLP-1 Drug Sales by Country (2021-2026)
5.1.2 Americas GLP-1 Drug Revenue by Country (2021-2026)
5.2 Americas GLP-1 Drug Sales by Type (2021-2026)
5.3 Americas GLP-1 Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Drug Sales by Region
6.1.1 APAC GLP-1 Drug Sales by Region (2021-2026)
6.1.2 APAC GLP-1 Drug Revenue by Region (2021-2026)
6.2 APAC GLP-1 Drug Sales by Type (2021-2026)
6.3 APAC GLP-1 Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Drug by Country
7.1.1 Europe GLP-1 Drug Sales by Country (2021-2026)
7.1.2 Europe GLP-1 Drug Revenue by Country (2021-2026)
7.2 Europe GLP-1 Drug Sales by Type (2021-2026)
7.3 Europe GLP-1 Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Drug by Country
8.1.1 Middle East & Africa GLP-1 Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa GLP-1 Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1 Drug Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1 Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Drug
10.3 Manufacturing Process Analysis of GLP-1 Drug
10.4 Industry Chain Structure of GLP-1 Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Drug Distributors
11.3 GLP-1 Drug Customer
12 WORLD FORECAST REVIEW FOR GLP-1 DRUG BY GEOGRAPHIC REGION
12.1 Global GLP-1 Drug Market Size Forecast by Region
12.1.1 Global GLP-1 Drug Forecast by Region (2027-2032)
12.1.2 Global GLP-1 Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1 Drug Forecast by Type (2027-2032)
12.7 Global GLP-1 Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Drug Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly GLP-1 Drug Product Portfolios and Specifications
13.2.3 Eli Lilly GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca GLP-1 Drug Product Portfolios and Specifications
13.3.3 AstraZeneca GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi GLP-1 Drug Product Portfolios and Specifications
13.4.3 Sanofi GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Pfizer Inc
13.5.1 Pfizer Inc Company Information
13.5.2 Pfizer Inc GLP-1 Drug Product Portfolios and Specifications
13.5.3 Pfizer Inc GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Pfizer Inc Main Business Overview
13.5.5 Pfizer Inc Latest Developments
13.6 Hanmi Pharmaceutical Co
13.6.1 Hanmi Pharmaceutical Co Company Information
13.6.2 Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolios and Specifications
13.6.3 Hanmi Pharmaceutical Co GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hanmi Pharmaceutical Co Main Business Overview
13.6.5 Hanmi Pharmaceutical Co Latest Developments
13.7 Teva Pharmaceutical Industries Ltd
13.7.1 Teva Pharmaceutical Industries Ltd Company Information
13.7.2 Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim GLP-1 Drug Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 GlaxoSmithKline (GSK)
13.9.1 GlaxoSmithKline (GSK) Company Information
13.9.2 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolios and Specifications
13.9.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GlaxoSmithKline (GSK) Main Business Overview
13.9.5 GlaxoSmithKline (GSK) Latest Developments
13.10 Huadong Medicine
13.10.1 Huadong Medicine Company Information
13.10.2 Huadong Medicine GLP-1 Drug Product Portfolios and Specifications
13.10.3 Huadong Medicine GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Huadong Medicine Main Business Overview
13.10.5 Huadong Medicine Latest Developments
13.11 Gan & Lee Pharmaceuticals
13.11.1 Gan & Lee Pharmaceuticals Company Information
13.11.2 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolios and Specifications
13.11.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Gan & Lee Pharmaceuticals Main Business Overview
13.11.5 Gan & Lee Pharmaceuticals Latest Developments
13.12 Tonghua Dongbao
13.12.1 Tonghua Dongbao Company Information
13.12.2 Tonghua Dongbao GLP-1 Drug Product Portfolios and Specifications
13.12.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tonghua Dongbao Main Business Overview
13.12.5 Tonghua Dongbao Latest Developments
13.13 Shanghai Benemae Pharmaceutical Corporation
13.13.1 Shanghai Benemae Pharmaceutical Corporation Company Information
13.13.2 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolios and Specifications
13.13.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Benemae Pharmaceutical Corporation Main Business Overview
13.13.5 Shanghai Benemae Pharmaceutical Corporation Latest Developments
13.14 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
13.14.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
13.14.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
13.14.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business Overview
13.14.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
13.15 PegBio Co., Ltd
13.15.1 PegBio Co., Ltd Company Information
13.15.2 PegBio Co., Ltd GLP-1 Drug Product Portfolios and Specifications
13.15.3 PegBio Co., Ltd GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 PegBio Co., Ltd Main Business Overview
13.15.5 PegBio Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GLP-1 Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GLP-1 Drug by Country/Region, 2021, 2025 & 2032
2.2 GLP-1 Drug Segment by Type
2.2.1 Short-acting GLP-1 Drug
2.2.2 Long-acting GLP-1 Drug
2.2.3 GLP-1 Drug Sales by Type
2.2.3.1 Global GLP-1 Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global GLP-1 Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global GLP-1 Drug Sale Price by Type (2021-2026)
2.3 GLP-1 Drug Segment by Application
2.3.1 Obesity
2.3.2 Type 2 Diabetes (T2DM)
2.3.3 Cardiovascular and Cerebrovascular Diseases (CVD)
2.3.4 Non-alcoholic Steatohepatitis (NASH)
2.3.5 Alzheimer's Disease (AD)
2.3.6 GLP-1 Drug Sales by Application
2.3.6.1 Global GLP-1 Drug Sale Market Share by Application (2021-2026)
2.3.6.2 Global GLP-1 Drug Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global GLP-1 Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Drug Breakdown Data by Company
3.1.1 Global GLP-1 Drug Annual Sales by Company (2021-2026)
3.1.2 Global GLP-1 Drug Sales Market Share by Company (2021-2026)
3.2 Global GLP-1 Drug Annual Revenue by Company (2021-2026)
3.2.1 Global GLP-1 Drug Revenue by Company (2021-2026)
3.2.2 Global GLP-1 Drug Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1 Drug Sale Price by Company
3.4 Key Manufacturers GLP-1 Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Drug Product Location Distribution
3.4.2 Players GLP-1 Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 DRUG BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global GLP-1 Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GLP-1 Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1 Drug Market Size by Country/Region (2021-2026)
4.2.1 Global GLP-1 Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global GLP-1 Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1 Drug Sales Growth
4.4 APAC GLP-1 Drug Sales Growth
4.5 Europe GLP-1 Drug Sales Growth
4.6 Middle East & Africa GLP-1 Drug Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Drug Sales by Country
5.1.1 Americas GLP-1 Drug Sales by Country (2021-2026)
5.1.2 Americas GLP-1 Drug Revenue by Country (2021-2026)
5.2 Americas GLP-1 Drug Sales by Type (2021-2026)
5.3 Americas GLP-1 Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Drug Sales by Region
6.1.1 APAC GLP-1 Drug Sales by Region (2021-2026)
6.1.2 APAC GLP-1 Drug Revenue by Region (2021-2026)
6.2 APAC GLP-1 Drug Sales by Type (2021-2026)
6.3 APAC GLP-1 Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Drug by Country
7.1.1 Europe GLP-1 Drug Sales by Country (2021-2026)
7.1.2 Europe GLP-1 Drug Revenue by Country (2021-2026)
7.2 Europe GLP-1 Drug Sales by Type (2021-2026)
7.3 Europe GLP-1 Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Drug by Country
8.1.1 Middle East & Africa GLP-1 Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa GLP-1 Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1 Drug Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1 Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Drug
10.3 Manufacturing Process Analysis of GLP-1 Drug
10.4 Industry Chain Structure of GLP-1 Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Drug Distributors
11.3 GLP-1 Drug Customer
12 WORLD FORECAST REVIEW FOR GLP-1 DRUG BY GEOGRAPHIC REGION
12.1 Global GLP-1 Drug Market Size Forecast by Region
12.1.1 Global GLP-1 Drug Forecast by Region (2027-2032)
12.1.2 Global GLP-1 Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1 Drug Forecast by Type (2027-2032)
12.7 Global GLP-1 Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Drug Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly GLP-1 Drug Product Portfolios and Specifications
13.2.3 Eli Lilly GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca GLP-1 Drug Product Portfolios and Specifications
13.3.3 AstraZeneca GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi GLP-1 Drug Product Portfolios and Specifications
13.4.3 Sanofi GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Pfizer Inc
13.5.1 Pfizer Inc Company Information
13.5.2 Pfizer Inc GLP-1 Drug Product Portfolios and Specifications
13.5.3 Pfizer Inc GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Pfizer Inc Main Business Overview
13.5.5 Pfizer Inc Latest Developments
13.6 Hanmi Pharmaceutical Co
13.6.1 Hanmi Pharmaceutical Co Company Information
13.6.2 Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolios and Specifications
13.6.3 Hanmi Pharmaceutical Co GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hanmi Pharmaceutical Co Main Business Overview
13.6.5 Hanmi Pharmaceutical Co Latest Developments
13.7 Teva Pharmaceutical Industries Ltd
13.7.1 Teva Pharmaceutical Industries Ltd Company Information
13.7.2 Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolios and Specifications
13.7.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.7.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.8 Boehringer Ingelheim
13.8.1 Boehringer Ingelheim Company Information
13.8.2 Boehringer Ingelheim GLP-1 Drug Product Portfolios and Specifications
13.8.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Boehringer Ingelheim Main Business Overview
13.8.5 Boehringer Ingelheim Latest Developments
13.9 GlaxoSmithKline (GSK)
13.9.1 GlaxoSmithKline (GSK) Company Information
13.9.2 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolios and Specifications
13.9.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 GlaxoSmithKline (GSK) Main Business Overview
13.9.5 GlaxoSmithKline (GSK) Latest Developments
13.10 Huadong Medicine
13.10.1 Huadong Medicine Company Information
13.10.2 Huadong Medicine GLP-1 Drug Product Portfolios and Specifications
13.10.3 Huadong Medicine GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Huadong Medicine Main Business Overview
13.10.5 Huadong Medicine Latest Developments
13.11 Gan & Lee Pharmaceuticals
13.11.1 Gan & Lee Pharmaceuticals Company Information
13.11.2 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolios and Specifications
13.11.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Gan & Lee Pharmaceuticals Main Business Overview
13.11.5 Gan & Lee Pharmaceuticals Latest Developments
13.12 Tonghua Dongbao
13.12.1 Tonghua Dongbao Company Information
13.12.2 Tonghua Dongbao GLP-1 Drug Product Portfolios and Specifications
13.12.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Tonghua Dongbao Main Business Overview
13.12.5 Tonghua Dongbao Latest Developments
13.13 Shanghai Benemae Pharmaceutical Corporation
13.13.1 Shanghai Benemae Pharmaceutical Corporation Company Information
13.13.2 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolios and Specifications
13.13.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shanghai Benemae Pharmaceutical Corporation Main Business Overview
13.13.5 Shanghai Benemae Pharmaceutical Corporation Latest Developments
13.14 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
13.14.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
13.14.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
13.14.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business Overview
13.14.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
13.15 PegBio Co., Ltd
13.15.1 PegBio Co., Ltd Company Information
13.15.2 PegBio Co., Ltd GLP-1 Drug Product Portfolios and Specifications
13.15.3 PegBio Co., Ltd GLP-1 Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 PegBio Co., Ltd Main Business Overview
13.15.5 PegBio Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1 Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1 Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Short-acting GLP-1 Drug
Table 4. Major Players of Long-acting GLP-1 Drug
Table 5. Global GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global GLP-1 Drug Sales Market Share by Type (2021-2026)
Table 7. Global GLP-1 Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global GLP-1 Drug Revenue Market Share by Type (2021-2026)
Table 9. Global GLP-1 Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global GLP-1 Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global GLP-1 Drug Sale Market Share by Application (2021-2026)
Table 12. Global GLP-1 Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global GLP-1 Drug Revenue Market Share by Application (2021-2026)
Table 14. Global GLP-1 Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global GLP-1 Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global GLP-1 Drug Sales Market Share by Company (2021-2026)
Table 17. Global GLP-1 Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global GLP-1 Drug Revenue Market Share by Company (2021-2026)
Table 19. Global GLP-1 Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers GLP-1 Drug Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Drug Products Offered
Table 22. GLP-1 Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global GLP-1 Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global GLP-1 Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global GLP-1 Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global GLP-1 Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global GLP-1 Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global GLP-1 Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global GLP-1 Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas GLP-1 Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas GLP-1 Drug Sales Market Share by Country (2021-2026)
Table 35. Americas GLP-1 Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas GLP-1 Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC GLP-1 Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC GLP-1 Drug Sales Market Share by Region (2021-2026)
Table 40. APAC GLP-1 Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC GLP-1 Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe GLP-1 Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe GLP-1 Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe GLP-1 Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa GLP-1 Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa GLP-1 Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa GLP-1 Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Drug
Table 52. Key Market Challenges & Risks of GLP-1 Drug
Table 53. Key Industry Trends of GLP-1 Drug
Table 54. GLP-1 Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Drug Distributors List
Table 57. GLP-1 Drug Customer List
Table 58. Global GLP-1 Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global GLP-1 Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas GLP-1 Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC GLP-1 Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC GLP-1 Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe GLP-1 Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa GLP-1 Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global GLP-1 Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global GLP-1 Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global GLP-1 Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global GLP-1 Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Drug Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. Eli Lilly Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Eli Lilly GLP-1 Drug Product Portfolios and Specifications
Table 79. Eli Lilly GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Eli Lilly Main Business
Table 81. Eli Lilly Latest Developments
Table 82. AstraZeneca Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. AstraZeneca GLP-1 Drug Product Portfolios and Specifications
Table 84. AstraZeneca GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Latest Developments
Table 87. Sanofi Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi GLP-1 Drug Product Portfolios and Specifications
Table 89. Sanofi GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. Pfizer Inc Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Inc GLP-1 Drug Product Portfolios and Specifications
Table 94. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Pfizer Inc Main Business
Table 96. Pfizer Inc Latest Developments
Table 97. Hanmi Pharmaceutical Co Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolios and Specifications
Table 99. Hanmi Pharmaceutical Co GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Hanmi Pharmaceutical Co Main Business
Table 101. Hanmi Pharmaceutical Co Latest Developments
Table 102. Teva Pharmaceutical Industries Ltd Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolios and Specifications
Table 104. Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Teva Pharmaceutical Industries Ltd Main Business
Table 106. Teva Pharmaceutical Industries Ltd Latest Developments
Table 107. Boehringer Ingelheim Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Boehringer Ingelheim GLP-1 Drug Product Portfolios and Specifications
Table 109. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Boehringer Ingelheim Main Business
Table 111. Boehringer Ingelheim Latest Developments
Table 112. GlaxoSmithKline (GSK) Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolios and Specifications
Table 114. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. GlaxoSmithKline (GSK) Main Business
Table 116. GlaxoSmithKline (GSK) Latest Developments
Table 117. Huadong Medicine Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Huadong Medicine GLP-1 Drug Product Portfolios and Specifications
Table 119. Huadong Medicine GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Huadong Medicine Main Business
Table 121. Huadong Medicine Latest Developments
Table 122. Gan & Lee Pharmaceuticals Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolios and Specifications
Table 124. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Gan & Lee Pharmaceuticals Main Business
Table 126. Gan & Lee Pharmaceuticals Latest Developments
Table 127. Tonghua Dongbao Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Tonghua Dongbao GLP-1 Drug Product Portfolios and Specifications
Table 129. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Tonghua Dongbao Main Business
Table 131. Tonghua Dongbao Latest Developments
Table 132. Shanghai Benemae Pharmaceutical Corporation Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolios and Specifications
Table 134. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shanghai Benemae Pharmaceutical Corporation Main Business
Table 136. Shanghai Benemae Pharmaceutical Corporation Latest Developments
Table 137. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
Table 139. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business
Table 141. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
Table 142. PegBio Co., Ltd Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. PegBio Co., Ltd GLP-1 Drug Product Portfolios and Specifications
Table 144. PegBio Co., Ltd GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. PegBio Co., Ltd Main Business
Table 146. PegBio Co., Ltd Latest Developments
Table 1. GLP-1 Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1 Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Short-acting GLP-1 Drug
Table 4. Major Players of Long-acting GLP-1 Drug
Table 5. Global GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global GLP-1 Drug Sales Market Share by Type (2021-2026)
Table 7. Global GLP-1 Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global GLP-1 Drug Revenue Market Share by Type (2021-2026)
Table 9. Global GLP-1 Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global GLP-1 Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global GLP-1 Drug Sale Market Share by Application (2021-2026)
Table 12. Global GLP-1 Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global GLP-1 Drug Revenue Market Share by Application (2021-2026)
Table 14. Global GLP-1 Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global GLP-1 Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global GLP-1 Drug Sales Market Share by Company (2021-2026)
Table 17. Global GLP-1 Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global GLP-1 Drug Revenue Market Share by Company (2021-2026)
Table 19. Global GLP-1 Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers GLP-1 Drug Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Drug Products Offered
Table 22. GLP-1 Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global GLP-1 Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global GLP-1 Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global GLP-1 Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global GLP-1 Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global GLP-1 Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global GLP-1 Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global GLP-1 Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas GLP-1 Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas GLP-1 Drug Sales Market Share by Country (2021-2026)
Table 35. Americas GLP-1 Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas GLP-1 Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC GLP-1 Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC GLP-1 Drug Sales Market Share by Region (2021-2026)
Table 40. APAC GLP-1 Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC GLP-1 Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe GLP-1 Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe GLP-1 Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe GLP-1 Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa GLP-1 Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa GLP-1 Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa GLP-1 Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa GLP-1 Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Drug
Table 52. Key Market Challenges & Risks of GLP-1 Drug
Table 53. Key Industry Trends of GLP-1 Drug
Table 54. GLP-1 Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Drug Distributors List
Table 57. GLP-1 Drug Customer List
Table 58. Global GLP-1 Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global GLP-1 Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas GLP-1 Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC GLP-1 Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC GLP-1 Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe GLP-1 Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa GLP-1 Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa GLP-1 Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global GLP-1 Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global GLP-1 Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global GLP-1 Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global GLP-1 Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Drug Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. Eli Lilly Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Eli Lilly GLP-1 Drug Product Portfolios and Specifications
Table 79. Eli Lilly GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Eli Lilly Main Business
Table 81. Eli Lilly Latest Developments
Table 82. AstraZeneca Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. AstraZeneca GLP-1 Drug Product Portfolios and Specifications
Table 84. AstraZeneca GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Latest Developments
Table 87. Sanofi Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi GLP-1 Drug Product Portfolios and Specifications
Table 89. Sanofi GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. Pfizer Inc Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Inc GLP-1 Drug Product Portfolios and Specifications
Table 94. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Pfizer Inc Main Business
Table 96. Pfizer Inc Latest Developments
Table 97. Hanmi Pharmaceutical Co Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolios and Specifications
Table 99. Hanmi Pharmaceutical Co GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Hanmi Pharmaceutical Co Main Business
Table 101. Hanmi Pharmaceutical Co Latest Developments
Table 102. Teva Pharmaceutical Industries Ltd Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolios and Specifications
Table 104. Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Teva Pharmaceutical Industries Ltd Main Business
Table 106. Teva Pharmaceutical Industries Ltd Latest Developments
Table 107. Boehringer Ingelheim Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Boehringer Ingelheim GLP-1 Drug Product Portfolios and Specifications
Table 109. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Boehringer Ingelheim Main Business
Table 111. Boehringer Ingelheim Latest Developments
Table 112. GlaxoSmithKline (GSK) Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolios and Specifications
Table 114. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. GlaxoSmithKline (GSK) Main Business
Table 116. GlaxoSmithKline (GSK) Latest Developments
Table 117. Huadong Medicine Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Huadong Medicine GLP-1 Drug Product Portfolios and Specifications
Table 119. Huadong Medicine GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Huadong Medicine Main Business
Table 121. Huadong Medicine Latest Developments
Table 122. Gan & Lee Pharmaceuticals Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolios and Specifications
Table 124. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Gan & Lee Pharmaceuticals Main Business
Table 126. Gan & Lee Pharmaceuticals Latest Developments
Table 127. Tonghua Dongbao Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Tonghua Dongbao GLP-1 Drug Product Portfolios and Specifications
Table 129. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Tonghua Dongbao Main Business
Table 131. Tonghua Dongbao Latest Developments
Table 132. Shanghai Benemae Pharmaceutical Corporation Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolios and Specifications
Table 134. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Shanghai Benemae Pharmaceutical Corporation Main Business
Table 136. Shanghai Benemae Pharmaceutical Corporation Latest Developments
Table 137. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolios and Specifications
Table 139. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Main Business
Table 141. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Latest Developments
Table 142. PegBio Co., Ltd Basic Information, GLP-1 Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. PegBio Co., Ltd GLP-1 Drug Product Portfolios and Specifications
Table 144. PegBio Co., Ltd GLP-1 Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. PegBio Co., Ltd Main Business
Table 146. PegBio Co., Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of GLP-1 Drug
Figure 2. GLP-1 Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global GLP-1 Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1 Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1 Drug Sales Market Share by Country/Region (2025)
Figure 10. GLP-1 Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Short-acting GLP-1 Drug
Figure 12. Product Picture of Long-acting GLP-1 Drug
Figure 13. Global GLP-1 Drug Sales Market Share by Type in 2026
Figure 14. Global GLP-1 Drug Revenue Market Share by Type (2021-2026)
Figure 15. GLP-1 Drug Consumed in Obesity
Figure 16. Global GLP-1 Drug Market: Obesity (2021-2026) & (K Units)
Figure 17. GLP-1 Drug Consumed in Type 2 Diabetes (T2DM)
Figure 18. Global GLP-1 Drug Market: Type 2 Diabetes (T2DM) (2021-2026) & (K Units)
Figure 19. GLP-1 Drug Consumed in Cardiovascular and Cerebrovascular Diseases (CVD)
Figure 20. Global GLP-1 Drug Market: Cardiovascular and Cerebrovascular Diseases (CVD) (2021-2026) & (K Units)
Figure 21. GLP-1 Drug Consumed in Non-alcoholic Steatohepatitis (NASH)
Figure 22. Global GLP-1 Drug Market: Non-alcoholic Steatohepatitis (NASH) (2021-2026) & (K Units)
Figure 23. GLP-1 Drug Consumed in Alzheimer's Disease (AD)
Figure 24. Global GLP-1 Drug Market: Alzheimer's Disease (AD) (2021-2026) & (K Units)
Figure 25. Global GLP-1 Drug Sale Market Share by Application (2025)
Figure 26. Global GLP-1 Drug Revenue Market Share by Application in 2026
Figure 27. GLP-1 Drug Sales by Company in 2026 (K Units)
Figure 28. Global GLP-1 Drug Sales Market Share by Company in 2026
Figure 29. GLP-1 Drug Revenue by Company in 2026 ($ millions)
Figure 30. Global GLP-1 Drug Revenue Market Share by Company in 2026
Figure 31. Global GLP-1 Drug Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global GLP-1 Drug Revenue Market Share by Geographic Region in 2026
Figure 33. Americas GLP-1 Drug Sales 2021-2026 (K Units)
Figure 34. Americas GLP-1 Drug Revenue 2021-2026 ($ millions)
Figure 35. APAC GLP-1 Drug Sales 2021-2026 (K Units)
Figure 36. APAC GLP-1 Drug Revenue 2021-2026 ($ millions)
Figure 37. Europe GLP-1 Drug Sales 2021-2026 (K Units)
Figure 38. Europe GLP-1 Drug Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa GLP-1 Drug Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa GLP-1 Drug Revenue 2021-2026 ($ millions)
Figure 41. Americas GLP-1 Drug Sales Market Share by Country in 2026
Figure 42. Americas GLP-1 Drug Revenue Market Share by Country (2021-2026)
Figure 43. Americas GLP-1 Drug Sales Market Share by Type (2021-2026)
Figure 44. Americas GLP-1 Drug Sales Market Share by Application (2021-2026)
Figure 45. United States GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC GLP-1 Drug Sales Market Share by Region in 2026
Figure 50. APAC GLP-1 Drug Revenue Market Share by Region (2021-2026)
Figure 51. APAC GLP-1 Drug Sales Market Share by Type (2021-2026)
Figure 52. APAC GLP-1 Drug Sales Market Share by Application (2021-2026)
Figure 53. China GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 57. India GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe GLP-1 Drug Sales Market Share by Country in 2026
Figure 61. Europe GLP-1 Drug Revenue Market Share by Country (2021-2026)
Figure 62. Europe GLP-1 Drug Sales Market Share by Type (2021-2026)
Figure 63. Europe GLP-1 Drug Sales Market Share by Application (2021-2026)
Figure 64. Germany GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. France GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 66. UK GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa GLP-1 Drug Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa GLP-1 Drug Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa GLP-1 Drug Sales Market Share by Application (2021-2026)
Figure 72. Egypt GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of GLP-1 Drug in 2026
Figure 78. Manufacturing Process Analysis of GLP-1 Drug
Figure 79. Industry Chain Structure of GLP-1 Drug
Figure 80. Channels of Distribution
Figure 81. Global GLP-1 Drug Sales Market Forecast by Region (2027-2032)
Figure 82. Global GLP-1 Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global GLP-1 Drug Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global GLP-1 Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global GLP-1 Drug Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global GLP-1 Drug Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of GLP-1 Drug
Figure 2. GLP-1 Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global GLP-1 Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1 Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1 Drug Sales Market Share by Country/Region (2025)
Figure 10. GLP-1 Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Short-acting GLP-1 Drug
Figure 12. Product Picture of Long-acting GLP-1 Drug
Figure 13. Global GLP-1 Drug Sales Market Share by Type in 2026
Figure 14. Global GLP-1 Drug Revenue Market Share by Type (2021-2026)
Figure 15. GLP-1 Drug Consumed in Obesity
Figure 16. Global GLP-1 Drug Market: Obesity (2021-2026) & (K Units)
Figure 17. GLP-1 Drug Consumed in Type 2 Diabetes (T2DM)
Figure 18. Global GLP-1 Drug Market: Type 2 Diabetes (T2DM) (2021-2026) & (K Units)
Figure 19. GLP-1 Drug Consumed in Cardiovascular and Cerebrovascular Diseases (CVD)
Figure 20. Global GLP-1 Drug Market: Cardiovascular and Cerebrovascular Diseases (CVD) (2021-2026) & (K Units)
Figure 21. GLP-1 Drug Consumed in Non-alcoholic Steatohepatitis (NASH)
Figure 22. Global GLP-1 Drug Market: Non-alcoholic Steatohepatitis (NASH) (2021-2026) & (K Units)
Figure 23. GLP-1 Drug Consumed in Alzheimer's Disease (AD)
Figure 24. Global GLP-1 Drug Market: Alzheimer's Disease (AD) (2021-2026) & (K Units)
Figure 25. Global GLP-1 Drug Sale Market Share by Application (2025)
Figure 26. Global GLP-1 Drug Revenue Market Share by Application in 2026
Figure 27. GLP-1 Drug Sales by Company in 2026 (K Units)
Figure 28. Global GLP-1 Drug Sales Market Share by Company in 2026
Figure 29. GLP-1 Drug Revenue by Company in 2026 ($ millions)
Figure 30. Global GLP-1 Drug Revenue Market Share by Company in 2026
Figure 31. Global GLP-1 Drug Sales Market Share by Geographic Region (2021-2026)
Figure 32. Global GLP-1 Drug Revenue Market Share by Geographic Region in 2026
Figure 33. Americas GLP-1 Drug Sales 2021-2026 (K Units)
Figure 34. Americas GLP-1 Drug Revenue 2021-2026 ($ millions)
Figure 35. APAC GLP-1 Drug Sales 2021-2026 (K Units)
Figure 36. APAC GLP-1 Drug Revenue 2021-2026 ($ millions)
Figure 37. Europe GLP-1 Drug Sales 2021-2026 (K Units)
Figure 38. Europe GLP-1 Drug Revenue 2021-2026 ($ millions)
Figure 39. Middle East & Africa GLP-1 Drug Sales 2021-2026 (K Units)
Figure 40. Middle East & Africa GLP-1 Drug Revenue 2021-2026 ($ millions)
Figure 41. Americas GLP-1 Drug Sales Market Share by Country in 2026
Figure 42. Americas GLP-1 Drug Revenue Market Share by Country (2021-2026)
Figure 43. Americas GLP-1 Drug Sales Market Share by Type (2021-2026)
Figure 44. Americas GLP-1 Drug Sales Market Share by Application (2021-2026)
Figure 45. United States GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 46. Canada GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 47. Mexico GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 48. Brazil GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. APAC GLP-1 Drug Sales Market Share by Region in 2026
Figure 50. APAC GLP-1 Drug Revenue Market Share by Region (2021-2026)
Figure 51. APAC GLP-1 Drug Sales Market Share by Type (2021-2026)
Figure 52. APAC GLP-1 Drug Sales Market Share by Application (2021-2026)
Figure 53. China GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Japan GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 55. South Korea GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 56. Southeast Asia GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 57. India GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 58. Australia GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. China Taiwan GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. Europe GLP-1 Drug Sales Market Share by Country in 2026
Figure 61. Europe GLP-1 Drug Revenue Market Share by Country (2021-2026)
Figure 62. Europe GLP-1 Drug Sales Market Share by Type (2021-2026)
Figure 63. Europe GLP-1 Drug Sales Market Share by Application (2021-2026)
Figure 64. Germany GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 65. France GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 66. UK GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. Italy GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. Russia GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Middle East & Africa GLP-1 Drug Sales Market Share by Country (2021-2026)
Figure 70. Middle East & Africa GLP-1 Drug Sales Market Share by Type (2021-2026)
Figure 71. Middle East & Africa GLP-1 Drug Sales Market Share by Application (2021-2026)
Figure 72. Egypt GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 73. South Africa GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 74. Israel GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 75. Turkey GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 76. GCC Countries GLP-1 Drug Revenue Growth 2021-2026 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of GLP-1 Drug in 2026
Figure 78. Manufacturing Process Analysis of GLP-1 Drug
Figure 79. Industry Chain Structure of GLP-1 Drug
Figure 80. Channels of Distribution
Figure 81. Global GLP-1 Drug Sales Market Forecast by Region (2027-2032)
Figure 82. Global GLP-1 Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 83. Global GLP-1 Drug Sales Market Share Forecast by Type (2027-2032)
Figure 84. Global GLP-1 Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 85. Global GLP-1 Drug Sales Market Share Forecast by Application (2027-2032)
Figure 86. Global GLP-1 Drug Revenue Market Share Forecast by Application (2027-2032)
